Money Laundering Case: Delhi court takes cognisance of ED charge sheet against Sterling Biotech director

Published On 2018-07-30 05:00 GMT   |   Update On 2018-07-30 05:00 GMT

New Delhi: A Delhi court has taken cognizance of a charge sheet filed by the ED against Gujarat-based pharma firm Sterling Biotech Limited's director Rajbhushan Omprakash Dixit in a bank loan fraud case of over Rs 5,000 crore.


Additional Sessions Judge Satish Arora took cognizance of the final report filed by the Enforcement Directorate's special public prosecutor Nitesh Rana and summoned the accused for August 8, the next date of hearing.


The court noted that Dixit was already out on bail in the money laundering case and directed him to appear on next date of hearing.


In the charge sheet, the ED has accused the company of taking loans of over Rs 5,000 crore from a consortium led by Andhra Bank which had turned into non-performing assets.


The charge sheet, filed through advocate A R Aditya, claimed that the accused committed offense punishable under sections 3 and 4 of Prevention of Money Laundering Act (PMLA).


The agency had in February arrested a former director of Andhra Bank, Anup Prakash Garg, and Delhi-based businessman Gagan Dhawan last November in connection with the case. They were named as accused in the cases by the ED and the CBI.


The ED registered a money laundering case in this instance after taking cognisance of an earlier CBI FIR.


The Central Bureau of Investigation had booked Sterling Biotech, its directors Chetan Jayantilal Sandesara, DiChetan Sandesara, Dixit, Nitin Jayantilal Sandesara and Vilas Joshi, chartered accountant Hemant Hathi, Garg and some unidentified persons in connection with the alleged bank fraud case.


The FIR claimed that the total pending dues of the group companies were Rs 5,383 crore as on December 31, 2016.

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News